- Administration of a phorbol ester to patients with hematological malignancies: preliminary results from a phase I clinical trial of 12-O-tetradecanoylphorbol-13-acetate. Strair, R.K., Schaar, D., Goodell, L., Aisner, J., Chin, K.V., Eid, J., Senzon, R., Cui, X.X., Han, Z.T., Knox, B., Rabson, A.B., Chang, R., Conney, A. Clin. Cancer Res. (2002)